Compare AdaptHealth Corp (AHCO) vs Vale SA (VALE) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AdaptHealth Corp vs Vale SA — how do they compare? AdaptHealth Corp trades at $10.04 (market cap $1.38B), while Vale SA trades at $14.08 (market cap $62.60B). The key difference: Vale SA is far larger — about 45.4× AdaptHealth Corp's market cap, and Vale SA pays a 8.57% dividend while AdaptHealth Corp pays none. Which is the better fit depends on your goals.
| AHCO | VALE | |
|---|---|---|
Market Cap | $1.38B | $62.60B |
Sector | Health | Basic Materials |
52-Week High | $13.38 | $17.82 |
52-Week Low | $8.68 | $9.53 |
Enterprise Value | $3.33B | $79.52B |
Dividend Yield | — | 8.57% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.
The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.
VALE trades at $14.69, down 2.0% over the past day, with a bearish technical signal from moving averages. The company reported mixed quarterly earnings, beating in Q3 2025 but missing in Q4 2025 and Q1 2026. Revenue for 2025 was $38.40 billion with a net income margin of 7.21%, while cash flow from operations remained strong at $8.80 billion. Recent news includes a board governance dispute and a $2.56 billion decarbonization investment plan announced on June 15, 2026 (Reuters).
The outlook is cautious with a consensus analyst price target of $18.30, implying potential upside, but risks include volatile iron ore prices, rising debt-to-asset ratios, and execution challenges. Earnings growth and cost management are key catalysts for stock performance amid macroeconomic uncertainties.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AdaptHealth Corp
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →About Vale SA
Vale is the world's largest iron ore miner and one of the largest diversified miners, along with BHP and Rio Tinto. Earnings are dominated by the bulk materials division, primarily iron ore and iron ore pellets, with minor contributions from iron ore proxies, including manganese and coal. The base metals division is much smaller, primarily consisting of nickel mines and smelters with a small contribution from copper.
Read more on VALE →
